Skip to Main Content

Author Details

David W Scott
University of British Columbia
1965
432
67
PMIDPaper TitleJournal TitlePublished Year
38079587CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.J Clin Oncol2024
35947123Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.Blood Adv2023
37595057Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.Blood Adv2023
37552496Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.Blood Adv2023
37584198ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.Br J Haematol2023
37259807Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score.Leuk Lymphoma2023
37190862Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma.Br J Haematol2023
37319384Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.J Clin Oncol2023
37086469Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada.Leuk Lymphoma2023
37084389Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.Blood2023
36945587Relapse timing is associated with distinct evolutionary dynamics in DLBCL.medRxiv2023
37307169Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma.Blood Adv2023
37038467Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.Hemasphere2023
37071673Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.Cancer Discov2023
36656933BTG1 mutation yields supercompetitive B cells primed for malignant transformation.Science2023
36849712Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.Histopathology2023
36824887Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas.bioRxiv2023
36632739Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma.Haematologica2023
36928381Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas.Nat Mater2023
36302166Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.Blood2023
36264161An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.Cancer Discov2023
36057749Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.Virchows Arch2023
34662378A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.Blood2022
35380993Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma.J Clin Invest2022
35439293Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.Blood Adv2022
35372792Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin.Hemasphere2022
35567407Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia.Br J Haematol2022
35816682Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.Blood Adv2022
35417812NFAT5 contributes to the pathogenesis of experimental autoimmune encephalomyelitis (EAE) and decrease of T regulatory cells in female mice.Cell Immunol2022
35749607Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma.Leuk Lymphoma2022
36075016The outcome of older adults with classic Hodgkin lymphoma in British Columbia.Blood Adv2022
36001803Genomic profiling for clinical decision making in lymphoid neoplasms.Blood2022
35963941Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial.Leukemia2022
35961783Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia.Br J Haematol2022
36030304Response to "The WHO classification of haematolymphoid tumours" (Editorial).Leukemia2022
36351924Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk.Nat Commun2022
36219238Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series.Virchows Arch2022
36377659Until programmed death do us tolerant.J Clin Invest2022
36343517High K<sup>+</sup> intake alleviates experimental autoimmune encephalomyelitis (EAE) and increases T regulatory cells.Cell Immunol2022
35205656Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60.Cancers (Basel)2022
32817292Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.Haematologica2021
35363869Harnessing Mitochondrial Mutations to ATAC Clonal Evolution in CLL.Cancer Discov2021
33684939Characterization of DLBCL with a PMBL gene expression signature.Blood2021
33570635Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.Blood Adv2021
33621109ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.J Clin Oncol2021
33670870Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling.Cancers (Basel)2021
33636392Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin.J Mol Diagn2021
33555941Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.J Clin Oncol2021
34438445Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.Blood Adv2021
34615710Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.Proc Natl Acad Sci U S A2021
  • 1 - 50 of 432

Recommended Authors

Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 2
Chance John Luckey
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Nan-Hua Chang
Krembil Research Institute, University Health Network
Career Start Year 1991
Number of shared co-authors 0
Jason G Cyster
University of California san francisco
Career Start Year 1990
Number of shared co-authors 4
Frances E Lund
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Qi Wu
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Mary M Tomayko
Yale University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Ursula Grohmann
University of Perugia
Career Start Year 1988
Number of shared co-authors 0
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Frances T Hakim
National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Su M Metcalfe
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 1
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 4
Peter D Burrows
University of Alabama at Birmingham
Career Start Year 1978
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 3
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 2
Carl A K Borrebaeck
Lund University
Career Start Year 1977
Number of shared co-authors 0
Ann Marshak-Rothstein
University of Massachusetts School of Medicine
Career Start Year 1976
Number of shared co-authors 1
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 1
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 1
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 3
Ellen R Richie
The University of Texas MD Anderson Cancer Center
Career Start Year 1970
Number of shared co-authors 0
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 5
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 2
John R Wunderlich
National Cancer Institute
Career Start Year 1963
Number of shared co-authors 0

Collaborators

Ryan D Morin
Simon Fraser University
Co-authored papers 38
Marco A Marra
University of British Columbia
Co-authored papers 31
Andrew J Mungall
Co-authored papers 21
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers 17
Lauren C Chong
University of British Columbia
Co-authored papers 15
Louis M Staudt
National Cancer Institute, National Institutes of Health
Co-authored papers 14
Ari Melnick
Co-authored papers 14
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 13
Anne S De Groot
University of Georgia
Co-authored papers 11
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 10
Rakesh P Patel
University of Alabama at Birmingham, USA Center for Free Radical Biology
Co-authored papers 9
Ali Bashashati
University of British Columbia
Co-authored papers 8
Kathleen P Pratt
Uniformed Services University of the Health Sciences
Co-authored papers 8
Olivier Elemento
Meyer Cancer Center
Co-authored papers 7
Fred Sanfilippo
Emory University
Co-authored papers 7
Bruno M Grande
Simon Fraser University
Co-authored papers 6
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 6
Lois Shepherd
Queens University
Co-authored papers 6
Steven J M Jones
University of British Columbia
Co-authored papers 5
Richard A Moore
Co-authored papers 5
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 5
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Reiner Siebert
Co-authored papers 4
Prasath Pararajalingam
Simon Fraser University
Co-authored papers 4
Hennady P Shulha
BC Children's Hospital Research Institute
Co-authored papers 4
William D Martin
EpiVax Inc.
Co-authored papers 4
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Co-authored papers 4
Barbara J Mann
University of Virginia
Co-authored papers 3
Martin Hirst
University of British Columbia
Co-authored papers 3
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 3
Release 1.2